Back to top

RBC Capital Remains a Buy on Repligen (RGEN)

In a report released on July 22, Dan Leonard from RBC Capital maintained a Buy rating on Repligen, with a price target of $160.00. The company’s sh...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Repligen Corporation (RGEN)